Table 1.

Main inclusion and exclusion criteria for the study participants

Study	Inclusion Criteria	Exclusion Criteria
1	Renal cancer > 2 cm in size with planned surgical resection	Chronic renal insufficiency with eGFR <30 mL/min/1.73m2
2	Locally advanced or metastatic pancreas cancer on chemotherapy ECOG functional status 0-2	Prior radiation therapy for pancreas cancer New chemotherapy initiated <14 days Thiazolidinedione use within 12 months History of HIV infection Others* (ref - NCT01838317)
3	History of DM2 Insulin >1.5 units/kg/day HbA1c 7.5 – 11% Stable comorbidities, treatment regimen, oral hypoglycemics	Type 1 diabetes mellitus History of other pancreatic disease End stage renal disease Current use of steroid or incretin therapy Others* (ref - NCT01505673)
All	Age >18 years Able to provide informed consent Physically able to tolerate MRI mDixon-Quant sequence performed	Contraindicaition to MRI Pregnant or lactating women Claustrophobia Weight > 400 lbs

Legends: ECOG – Eastern Cooperative Oncology Group; DM2 – type 2 diabetes mellitus; eGFR = estimated glomerular filtration rate; NYHA – New York Heart Association;

^*other exclusion criteria unrelated to glucose or lipid metabolism detailed in http://www.clinicaltrials.gov under referenced identifier.